Comparative in vitro activity of BAY 12-8039 and five other antimicrobial agents against anaerobic bacteria. Eur. J. Clin. Microbiol. Infect.
Seres Therapeutics, a Cambridge, Mass., biotechnology company, is conducting Phase II clinical trials of SER-109, a four-pill regimen made from spore-forming anaerobic bacteria
In vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteria. Antimicrob.